chrisvoncsefalvay/vaers-outcomes huggingface dataset:
received doses administered more than 12 hours post puncture; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received doses administered more than 12 hours post puncture) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017e21a) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (received doses administered more than 12 hours post puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received doses administered more than 12 hours post puncture) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported No treatment medications were reported. This is a case of expired product administered for this patient of unknown age and unknown gender with no relevant medical history, with no associated events reported after administration of an unspecified dose of the Moderna COVID-19 Vaccine. The benefit-risk relationship of the Moderna COVID-19 Vaccine is not affected by this report.; Sender's Comments: This is a case of expired product administered for this patient of unknown age and unknown gender with no relevant medical history, with no associated events reported after administration of an unspecified dose of the Moderna COVID-19 Vaccine. The benefit-risk relationship of the Moderna COVID-19 Vaccine is not affected by this report.
After second dose, menstrual cycle was late 15 days and is no longer consistent; varying between 17 and 45 days between. Prior, my cycle was lime clock work where I could plan vacations around the event.  Immediately following the booster, my arm felt incredibly sore. My neck and face felt tight. 15 hours later, my hands were cramping. My left arm has a significant decrease in range of motion due to soreness. My muscles ache all over.
This spontaneous report was received from a medical assistant via Center and refers to a patient of unknown age and gender. The patient's relevant medical and past drug histories were unknown. The patients concomitant medications were unknown. On an unknown date, the patient was vaccinated with VARIVAX, that underwent a temperature excursion, subcutaneously in the back of the arm (lot # M008173, expiration date: 16-FEB-2018, dose was not provided). The patient did not experience any adverse reactions. It was unknown, if there was any relevant laboratory data. This is one of several reports received from the same reporter. Additional information has been requested.
Patient presented 5 days after vaccine administration with a lacunar stroke.  He had numbness in his right face and right hand which he woke up with on day 5.
Increasing pain in site of shot, flu like symptoms (muscle aches, shivering, headache and fever).
headache; This case was reported by a pharmacist via call center representative and described the occurrence of headache in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number NX952, expiry date 6th March 2020) for prophylaxis.   In April 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced headache. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the headache was recovered/resolved.   It was unknown if the reporter considered the headache to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. Till the time of reporting The patient did not received their second dose of Shingrix due to having a bad headache after receiving the first dose. The symptoms began the same day and had since resolved. Duration was unknown.  The patient took Benadryl for their symptoms. The reporter consented to follow up This case was linked to case US2019085102 same reporter.
I took 1 home test that was negative. Then took 2 tests local Dr. (PCR) and that was negative. Then a test with Dr. Primary PCP) and it was negative. I woke up at 3am in the morning and my throat was hurting, I didn't feel well and couldn't sleep. I found out my throat was beat red, so when I got up in the morning I took a home Binax test and it was. I have a 104 fever, a lot of chills. The first day I felt real bad, everything was hurting, felt like I was going to throw up. Headache for at least 3 days. I asked for an inhaler because when I start coughing it's seems to be only thing that calms it down. I am taking tasklovid because I couldn't get the antibodies. My throat was hurting and then I felt it moving to my chest so I took the tasklovid because of my history of bronchitis and pneumonia. My symptoms are moderate, it's getting better. I'm not sure it's from Covid-19 but I also got pink eye. I had my grandson there and was changing his diaper and he hit my eye with his finger.
patient experienced moderate rash on trunk, arms, thighs. Rash comes and goes. Patient has tried benadryl and calamine with no relief. Patient has follow up with provider on 12/30.
Pt has never had a history of irregular menses. Periods have always been regular and she has been on the same birth control pill for years without issues. States that she had the vaccine on 7/29/21 and then had her menses on 8/9-8/14 and 8/20/8/28 and then on 8/18 when she was due. States that this pattern continued in a similar fashion in September.
Patient states he developed severe fatigue & myalgias approximately 2 weeks after receiving the BEXSERO vaccine. The myalgias have resolved but the fatigue is persistent. Denies any localized site reactions.
Rash on head & arm, inject site, rt deltoid, hot & swollen skin hot, dry red rash mostly on head;
She came into the pharmacy today after an off-site flu clinic at her place of employment yesterday.  She had a local reaction the previous year so she marked with a sharpie where the shot was this year.  The arm turned red and hot and was swollen all the way down to her elbow.
Pt reported 5 in erythema around injection site and itching starting on day 3 after vaccination with blistering at injection site on day 5 after vaccination. Pt reported symptoms resolved day 9 after vaccination and nothing noted by RN or reported by patient on day of 2nd dose placement 9/19/22.
The day after both vaccines were given in the same arm over 2 inches apart the patient developed rigors, sweats and the vaccine site was hot, swollen and sore. He went thru multiple days of these symptoms then developed a severe cough. He went to the Urgent Care Center and was diagnosed on 11/28 with pneumonia and had just over 80% oxygen saturation. He has been to the doctor at least five times so far for the symptoms that he experienced.
No adverse event; Patient received a .25ml dose from pink cap and not blue cap vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received a .25ml dose from pink cap and not blue cap vaccine) and NO ADVERSE EVENT (No adverse event) in a 5-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 214K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Aug-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 24-Aug-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (Patient received a .25ml dose from pink cap and not blue cap vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received a .25ml dose from pink cap and not blue cap vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received a .25ml dose from pink cap and not blue cap vaccine).    Concomitant medication not reported.   It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  No other adverse reactions were reported.  Treatment medication not reported.
per patient about 15 minutes after receiving dose she experienced some numbness in her face and some dizziness similar to how she feels after eating calamari. Patient was talking OK but was given 50mg oral diphenhydramine at 1:03pm, did not report feeling any worse/was feeling slightly better after 30 minutes
I was supposed to receive the second shingles vaccine. I was accidentally given third covid vaccine. Just wanted someone to know.
Information has been received from a healthcare worker refers to an unspecified number of unspecified patients of unknown age. The healthcare worker reported the patients were administered an unspecified number of improperly stored doses of RECOMBIVAX HB (dose, route and lot# not reported). No adverse effect was reported. It was unknown if the patients sought medical attention. This is one of the several reports with the same reporter. Additional information has been requested.
feeling unwell; diarrhea; threw up all night; Stomach cramps; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach cramps), MALAISE (feeling unwell), DIARRHOEA (diarrhea) and VOMITING (threw up all night) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach cramps) and VOMITING (threw up all night). On 22-Apr-2021, the patient experienced DIARRHOEA (diarrhea). On an unknown date, the patient experienced MALAISE (feeling unwell). On 21-Apr-2021, VOMITING (threw up all night) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (Stomach cramps), MALAISE (feeling unwell) and DIARRHOEA (diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
patient was 2 month short of their 16th birthday when 3 dose(booster)was administered   Required age is 16yo or older
Information has been received from a registered nurse concerning a 19 year old male with an egg allergy who as a child was vaccinated with a first dose of measles virus vaccine live, mumps virus vaccine live, rubella virus vaccine live.  Subsequently, the patient developed an anaphylactic reaction.  Unspecified medical attention was sought.
sleeplessness; This spontaneous case was reported by a health care professional and describes the occurrence of INSOMNIA (sleeplessness) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Irritable bowel syndrome.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (sleeplessness). At the time of the report, INSOMNIA (sleeplessness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD21-050421 (Patient Link).
fatigue, fever ( around 99.5) , rapid heart beats, shortness of breath, almost fainting episodes, restlessness, headache, coughing.
The information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' concurrent condition, medical history and concomitant therapy were reported. On an unspecified date, an unspecified number of patients were vaccinated with an improperly stored dose of ROTATEQ (lot#M046000, expiration date 27-JUN-2018) (dosage, frequency and route were not reported) for prophylaxis (Incorrect product storage). The vaccine was stored at a temperature from 32F to 35 F for 6 days. There was no previous temperature excursion. Data logger was involved. No product quality complaint was involved. No further information was provided. No adverse effect reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1708USA003819: US-009507513-1707USA006766: US-009507513-1708USA004000:
p/vax pt swelling; redness; pain lt arm; weakness; diaphoresis; chills; feverish; 9/14 had erythema; tenderness;rt arm site of pneumovax was entirely asymptomatic
This is a spontaneous report from a contactable nurse (patient). A 58-year-old female patient received second single dose of BNT162B2 (Pfizer, batch/lot number and exp date not reported), intramuscular (vaccine location: Left arm) on 12Jan2021 11:00 for COVID-19 immunization. Facility type vaccine: Hospital. Medical history included allergies to penicillin. There were no other medical history. The patient was not pregnant. The patient did not have COVID prior vaccination. Other medications in two weeks include escitalopram oxalate (LEXAPRO) and meloxicam. There were no other vaccines in four weeks. The patient was previously given first single dose of BNT162B2 on 24Dec2020 10:30, Intramuscular (Right arm) for COVID-19 immunization. The patient previously took tetracycline and experienced allergies. The patient experienced severe joint pain in bilateral knees on 12Jan2021 22:00, and was still present 3 days post 2nd injection. No treatment was given for the event. The patient was not COVID tested post vaccination. The outcome of the event was not recovered. Information about lot/batch number has been requested.
Signs of infection, increase erythema around injection site 5cm x 5cm, warm to touch, increasing in site, palpable soft tissue swelling.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose:12/19/2020.pfizer Lot#EK5730 2nd dose:01/09/21.pfizerLot#EL3248 Diagnosed covid positive: 03/12/21 Asymptomatic at the time of diagnosis Exposure:Unknown Symptoms: (started on 03/13/21 )fever, chills, body aches(mild flu like symptoms)
Information was received on 28-SEP-2017 from a female consumer who is the mother of the patient, a 33 year old female with rheumatoid arthritis, autoimmune issues and asthma "since she was born" and the grandmother of the child who was vaccinated. The patient's child (age and gender unknown) was vaccinated with a dose of VARIVAX (lot, expiration, site and dose not reported) "10 days ago". Following the child's vaccination, the female patient (the child's mother) developed "a mild headache for four days" and was "lying in bed all day yesterday and last night got very sick with high fever and chills all night" last night. The patient's skin presently feels "raw and sensitive and burns as if her nerves are inflamed". She currently has 8 chickenpox lesions on her chest and neck. The reporter believes that the vaccine virus was transmitted through saliva as the recipient of the vaccine (the child) does not have a rash. The reporter stated that her state requires mandatory vaccination even though the vaccine recipient's parent has an autoimmune disorder. The reporter is contemplating legal action. Additional information has been requested.
Coughing, running nose, tightness in chest, hoarseness, aches, pains, exhaustion started 3 hours after injection extremely tired. Next day felt fine
Patient states that her left arm had red streaks stemming from the injection site all the way to her armpit. She also feels slightly nauseous and feverish.
Headache - took Aleve; lasted until the next day Tinnitis - lasted until next day
Chest pains, tightness in chest, heavy chest, dizziness.  Called 911, went to ER.  Multiple tests, bloodwork, revealed inflammation around heart. Also elevated troponin level.  Follow up appointment with pediatric cardiologist. More testing. Same results. Inflammation around his heart.
Skin flushing - diffuse, splotchy with pruritis, VSS lungs - clear; RRR; (+) abd complaints - nausea (-) emesis; CLARITIN 10mg po, PEPCID 40mg, BENADRYL 25mg po.
This spontaneous report was received from a pharmacist via Poison and Drug Center (PDC) regarding a currently 14-year-old female patient. The patient's concomitant medications included a prescription for an ear medication. Information on the patient's relevant medical history and concurrent conditions were not reported. On an unknown date in 2016 (also reported as when she was 12-year-old), the patient was vaccinated with the first dose of GARDASIL 9 (strength, frequency, lot# and expiry date was not reported) via intramuscular deltoid, for prevention of cervical cancer. On 05-JUL-2018, the patient was vaccinated with the second dose of GARDASIL 9 (lot # N022583, expiration date: 20-JUN-2020) suspension for intramuscular injection via intramuscular deltoid, for prevention of cervical cancer, 2 years apart. The patient's laboratory data was unknown at the time of report.
Injection site pain; rash at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain and injection site rash. On an unknown date, the outcome of the injection site pain and injection site rash were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain and injection site rash to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. Patient received the first Shingrix vaccine and initially had injection site pain, and then after several days she also developed a rash at the injection site. No other information reported. The reporter did not consent to follow-up.
Just a very sore arm, and itchiness at the injection site on March 23.  I hope within a few days it will go away.
runny nose; nausea after eating; soft stools; abdominal pain and cramping; Initial information received on 08-Sep-2020 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (patient herself).  This case involves a female patient (age not reported) who experienced nausea after eating (nausea), soft stools (faeces soft), abdominal pain and cramping (abdominal pain) and runny nose (rhinorrhoea), while she received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's medical history, past medical treatment, past vaccination, family history and concomitant medication were not provided.  On 01-Sep-2020, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot (lot number and expiry date were not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On 02-Sep-2020, the patient developed a non-serious nausea after eating (nausea), soft stools (faeces soft), abdominal pain and cramping (abdominal pain) one day following the administration of INFLUENZA QUADRIVAL A-B VACCINE. On an unknown date, the patient developed a non-serious runny nose (rhinorrhoea) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  Details of laboratory data was not reported.  It was not reported if the patient received any corrective treatment.  At the time of this report, outcome of the events were not reported (unknown).  There will be no information available on the batch number for this case.
Rash and redness on face and ears started on 03/18. Neck and  hands started few days later.  Raised,  severely itchy, skin dryness that is peeling, painful. Injection site is raised, warm to the touch. The reaction on the arm was noticed on 03/21.
I had chest paint, chest palpitations, fever, Couldn't breath very well, loose bowel movements and Started getting bruises all over my body but mostly on my legs and some on my abdomen, Really really tired, nausea, my feet were like ice. Two days later I went to the doctor and didn't give me anything and sent home. I am still having the palpitation.
Patient was admitted as Inpatient on 5/2/2022 due to Acute respiratory failure with hypercapnia. Per report, patient requested that dialysis treatment be discontinued 42 minutes early due to complaint of not feeling well.
Around 8pm I became very cold and tired. I took a bath, which is out of character, and tried to sleep. By 9 pm I was alternating between hot and cold sweats.  By 10 pm I was vomiting and defeating uncontrollably while still alternating between hot and cold sweats. I dry heaved until around 3 am and then finally passed out. My fever never exceeded right about 100 degrees. For the next 2 days I was incredibly exhausted with muscle aches and a minor headache. I didn?t return to baseline for approximately 6 days after the shot.
Pt recvd vax & exp h/a, nausea, dizziness, back pain & fatigue @ 1 hr intervals; 20JAN93 MD notes WBC in urine & prescribed septra c/o coughing, yellowish white sputum now; discomfort in back, rhonchi, WBC elevated; RUQ pain; liver enzy inc
pain in neck; Swollen lump on neck; Swollen bump at injection site on left arm; Shortness of breath; Rapid heartbeat; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (pain in neck), NECK MASS (Swollen lump on neck), VACCINATION SITE MASS (Swollen bump at injection site on left arm), DYSPNOEA (Shortness of breath) and HEART RATE INCREASED (Rapid heartbeat) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2021, the patient experienced NECK PAIN (pain in neck), NECK MASS (Swollen lump on neck), VACCINATION SITE MASS (Swollen bump at injection site on left arm), DYSPNOEA (Shortness of breath), HEART RATE INCREASED (Rapid heartbeat) and VACCINATION SITE PAIN (Pain at injection site). On 08-May-2021, DYSPNOEA (Shortness of breath) and HEART RATE INCREASED (Rapid heartbeat) had resolved. At the time of the report, NECK PAIN (pain in neck), NECK MASS (Swollen lump on neck), VACCINATION SITE MASS (Swollen bump at injection site on left arm) and VACCINATION SITE PAIN (Pain at injection site) outcome was unknown.            Concomitant medications included Depression medications.  treatment information was not provided   The action taken with mRNA-1273 with the events was considered as not applicable  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments   This case was linked to MOD-2021-114428 (Patient Link).
on 26oct77,pt was found unresponsive w/ cardiopulmonary arrest;resuscitation in er was ineffective;autopsy was unremarkable,COD was SIDS;